Final results of a phase II study of liposomal cisplatin
-vinorelbine combination as first-line treatment in HER2/neu negative metastatic breast cancer.
F. S. Farhat
No relevant relationships to disclose
S. Temraz
No relevant relationships to disclose
J. G. Kattan
No relevant relationships to disclose
K. Ibrahim
No relevant relationships to disclose
N. Bitar
No relevant relationships to disclose
N. Haddad
No relevant relationships to disclose
H. Hatoum
No relevant relationships to disclose
A. Shamseddine
No relevant relationships to disclose